Efficacy of buspirone in smoking cessation: A placebo-controlled trial

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 5, 1996, Pages 568-575

  Schneider, Nina G ^a   Olmstead, Richard E ^b   Steinberg, Craig ^b   Sloan, Kathleen ^b   Daims, Richard M ^b   Brown, Harvey V ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; PLACEBO;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING CESSATION; WITHDRAWAL REFLEX;

EID: 0029801377     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90153-8     Document Type: Article

References (26)

1. Jarvik ME, Schneider NG. Nicotine. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, editors. Substance abuse: a textbook. 2nd ed. Baltimore: Williams & Wilkins, 1992:334-56.
2. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995;155:1933-41.
3. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 1994;56:86-99.
4. Fagerstrom KO, Schneider NG, Lunell E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology (Berl) 1993;111:271-7.
5. Hughes JR. Non-nicotine pharmacotherapies for smoking cessation. J Drug Dev 1994;6:197-203.
6. Jann MW. Buspirone: an update on a unique anxiolytic agent. Pharmacotherapy 1988;8:100-16.
7. Taylor DP, Moon SL. Buspirone and related compounds as alternative anxiolytics. Neuropeptides 1991;19:15-9.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
9. Hughes JR, Higgins ST, Hatsukami D. Effects of abstinence from tobacco: a critical review. In: Kozlowski LT, Annis H, Cappell HD, et al., editors. Research advances in alcohol and drug problems. New York: Plenum Press, 1990:317-98.
10. Schneider NG, Jarvik ME, Forsythe AB. Nicotine vs placebo gum in the alleviation of withdrawal during smoking cessation. Addict Behav 1984;9:149-56.
11. Gross J, Stitzer ML. Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology (Berl) 1989;98:334-41.
12. Gawin F, Compton M, Byck R. Buspirone reduces smoking [letter]. Arch Gen Psychiatry 1989;46:288.
13. Robinson MD, Smith WA, Cederstrom EA, Sutherland DE. Buspirone effect on tobacco withdrawal symptoms: a pilot study. J Am Board Fam Pract 1991; 4:89-94.
14. Robinson MD, Pettice YL, Smith WA, Cederstrom EA, Sutherland DE, Davis H. Buspirone effect on tobacco withdrawal symptoms: A randomized placebo-controlled trial. J Am Board Fam Pract 1992;5:1-9.
15. West R, Hajek P, McNeill A. Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology (Berl) 1991;104:91-6.
16. Hilleman DE, Mohiuddin SM, Del Core MG, Sketch MH. Effect of buspirone on withdrawal symptoms associated with smoking cessation. Arch Intern Med 1992;152:350-2.
17. Fagerstrom KO, Schneider NG. Measuring nicotine dependence in tobacco smoking: a review of the Fagerstrom tolerance questionnaire. J Behav Med 1989; 12:159-82.
18. Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ, Van Vunakis H. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers. J Clin Psychopharmacol 1995;15:182-91.
19. Sachs DPL, Säwe U, Leischow S. Nicotine transdermal patch, smoking cessation and gender. In: Harris LS, editor. Problems of Drug Dependence, 1991: proceedings of the 53rd Annual Scientific Meeting. NIDA Research Monograph 119, USDHHS publ No (ADM)92-1888. Washington, DC: US Government Printing Office, 1992:367.
20. Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. JAMA 1994;271:595-600.
21. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA 1994;271:589-94.
22. Schneider NG, Olmstead RE, Nilsson F, Vaghaiwalla Mody F, Franzon M, Doan K. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 1996;91:1293-306.
23. Schneider NG. Smoker Complaint Scale (SCS), revised 1984. In: Kramer JJ, editor, 11th mental measurements year book. Lincoln, NE: Buros Institute of Mental Measurement, 1994:834.
24. McNair DM, Lorr M, Droppleman LF. EITS manual for the profile of mood states. San Diego: Educational and Industrial Testing Service, 1981.
25. Lerner I, Schneider NG. In Control: a home video freedom from smoking program: the American Lung Association in control programs. Chicago: MMI Video, 1986.
26. Dixon WJ, editor. BMDP statistical software manual. Berkeley, CA: University of California Press, 1990.